Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Almost never
In a randomized, double-blind, placebo-controlled trial, 98 participants were randomly assigned to receive weekly subcutaneous injections of Retatrutid (1mg, 4mg, 8mg, or 12mg) or placebo for 48 weeks
We compared GLP-1RAs with SGLT2 inhibitors and metformin and found that GLP-1RAs significantly reduced the incidence of major CVEs and mortality rate compared with metformin and second- or third-line glucose-lowering medications
Consulting healthcare providers about side effects ensures appropriate management and that the medications benefits outweigh the discomfort
In many states, semaglutide drugs can only be prescribed by a physician or nurse practitioner, though some states also grant prescriptive authority to physician assistants and advanced practice registered nurses
